These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7278577)

  • 1. [Which influenza vaccination is the best - with whole virus, split vaccine or subunit vaccines?].
    Klenk HD; Stickl H
    Med Welt; 1981 Jun; 32(25):1008-9. PubMed ID: 7278577
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivated influenza virus vaccines in children.
    Ruben FL
    Clin Infect Dis; 2004 Mar; 38(5):678-88. PubMed ID: 14986252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccine for children.
    Neuzil KM
    Clin Infect Dis; 2004 Mar; 38(5):689-91. PubMed ID: 14986253
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic reactions following influenza virus vaccination].
    Süss J; Schmidt S; Groh A; Vogt KH; Schmidt J
    Z Gesamte Hyg; 1985 Mar; 31(3):149-53. PubMed ID: 4013413
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unresolved problems in the specific prevention of influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 59():6-12. PubMed ID: 7187568
    [No Abstract]   [Full Text] [Related]  

  • 7. [Safety of viral vaccines (a review)].
    Peradze TV; Fridman EA
    Tr Inst Im Pastera; 1979; 52():9-18. PubMed ID: 550552
    [No Abstract]   [Full Text] [Related]  

  • 8. Pandemic H5N1 influenza vaccine development: an update.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of the 4th meeting on the "Evaluation of pandemic influenza prototype vaccines in clinical trials." World Health Organization, Geneva, Switzerland, 14-15 February 2008.
    Girard M; Palkonyay L; Kieny MP
    Vaccine; 2008 Sep; 26(39):4975-7. PubMed ID: 18514979
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reactogenicity and safety of inactivated chromatographic influenza vaccine in a contingent of immune donors being revaccinated].
    Tentser PS; Bundzen NG
    Tr Inst Im Pastera; 1979; 52():43-50. PubMed ID: 550546
    [No Abstract]   [Full Text] [Related]  

  • 12. Cold-adapted, live attenuated influenza vaccine.
    Glezen WP
    Expert Rev Vaccines; 2004 Apr; 3(2):131-9. PubMed ID: 15056039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza control in the 21st century: Optimizing protection of older adults.
    Monto AS; Ansaldi F; Aspinall R; McElhaney JE; Montaño LF; Nichol KL; Puig-Barberà J; Schmitt J; Stephenson I
    Vaccine; 2009 Aug; 27(37):5043-53. PubMed ID: 19559118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine decisions loom for new flu strain.
    Butler D
    Nature; 2009 May; 459(7244):144-5. PubMed ID: 19444174
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of vaccines against influenza A virus (H5N1).
    Li WC; Huang YC
    Chang Gung Med J; 2007; 30(4):294-304. PubMed ID: 17939259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.
    Hibbert CL; Piedra PA; McLaurin KK; Vesikari T; Mauskopf J; Mahadevia PJ
    Vaccine; 2007 Nov; 25(47):8010-20. PubMed ID: 17936446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.